Renal involvement in multiple myeloma: A 10-year study

Renal Failure

Volumn 22, Issue 4, 2000, Pages 465-477

  Sakhuja, Vinay ^a   Jha, Vivekanand ^a   Varma, Subhash ^a   Joshi, Kusum ^a   Gupta, Krishan L ^a   Sud, Kamal ^a   Kohli, Harbir S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Myeloma cast nephropathy; Plasma cell dyscrasia; Renal failure

Indexed keywords

AMINOGLYCOSIDE; BENCE JONES PROTEIN; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; BONE PAIN; CLINICAL FEATURE; DEHYDRATION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK FACTOR; SEPSIS; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0033922451     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100100888     Document Type: Article

References (41)

1. Editorial. Renal involvement in myeloma. Lancet 1:1202-1203, 1988.
2. Winearls CG: Acute myeloma kidney. Kidney Int 48:1347-1361,1995.
3. Alexanian R, Barlogie B, Dixon D: Renal failure in multiple myeloma: pathogenesis and prognostic implications. Arch Intern Med 150:1693-1695, 1990.
4. Pasquali S, Casanova S, Zuccheli A, Zuccheli P: Long-term survival of patients with acute and severe renal failure due to multiple myeloma. Clin Nephrol 34:247-254, 1990.
5. Pozzi C, Pasquali S, Donini U, et al..: Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Clin Nephrol 28:1-9,1987.
6. DeFronzo RA, Humphrey RL, Wright JR, Cooke CR: Acute renal failure in multiple myeloma. Medicine (Baltimore) 54:209-223,1975.
7. Cosio FG, Pence TV, Shapiro FL, Kjellstrand CE: Severe renal failure in multiple myeloma. Clin Nephrol 4:206-210, 1981.
8. Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE: Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis and chemotherapy. Arch Intern Med 150:863-869, 1990.
9. Torra R, Blade J, Cases A, et al..: Patients with multiple myeloma requiring long term dialysis: Presenting features, response to therapy and outcome in a series of 20 cases. Br J Haematol 91:854-859, 1995.
10. Kyle RA: Multiple myeloma: A review of 869 cases. Mayo Clin Proc 50:29-40, 1975.
11. Alexanian R, Dimopoulos M: The treatment of multiple myeloma. N Engl J Med 330:484-489, 1994.
12. Durie BGM, Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842-854, 1976.
13. Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J: Renal function in newly diagnosed multiple myeloma. A demographic study of 1353 patients. Eur J Haematol 53:207-212, 1994.
14. MacLennan ICM, Cooper EH, Chapman CE, Kelly RA, Crockson RA: Renal failure in myelomatosis. Eur J Haematol 43 (suppl 51):60-65, 1989.
15. MRC Working Party on Leukemia in Adults. Analysis and management of renal failure in the fourth MRC myelomatosis trial. Br Med J 288:1411-1416, 1984.
16. Kapadia SB: Multiple myeloma: A clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore) 59:380-392, 1980.
17. Martinez-Maldonado M, Yium J, Suki WN, Eknoyan G: Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chron Dis 24:221-237,1971.
18. Rota S, Mougenot B, Baudoin B, De Meyer Brasseur M, Le Maitre V, Michel C, Mignon F, Rondeau E, Vanttille P, Verroust P: Multiple myeloma and severe renal failure: a clinicopathological study of outcome and prognosis in 34 cases. Medicine (Baltimore) 66:126-137, 1987.
19. Johnson WJ, Kyle RA, Dahlberg PJ: Dialysis in the treatment of myeloma. Mayo Clin Proc 55:65-72, 1980.
20. Pasquali S, Zuccheli P, Casanova S, Cagnoli L, Conforloniri R, Pozzi C, Banfi G, Lupo A, Bertani T: Renal histological lesions and clinical syndromes in multiple myeloma: Clin Nephrol 27:222-228, 1987.
21. Cohen DJ, Sherman WH, Osserman EF, Appel GB. Acute renal failure in patients with multiple myeloma. Am J Med 76:247-256, 1984.
22. Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J: Perspectives in multiple myeloma: Survival, prognostic factors and disease complications in a single center between 1975 and 1988. Q J Med 79:517-525, 1991.
23. Zuccheli P, Pasquali S, Cagnoli L, Ferrari G: Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33:1175-1180, 1988.
24. McCarthy CS, Becker JA: Multiple myeloma and contrast media. Radiology 183: 519-521, 1992.
25. Bladé J, Lust JA, Kyle RA: Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 12:2398-2404, 1994.
26. Ganeval D, Noel LN, Preud' homme JL, Droz D, Grunfeld JP: Light chain deposition disease: its relation with AL type amyloidosis. Kidney Int 26:1-9, 1984.
27. Ivanyi B: Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence-Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 114:986-987, 1990.
28. Pirani CL, Silva F, D'Agati V, Chander P, Striker L: Multiple myeloma. Renal lesions in plasma cell dyscrasias: Ultrastructural observations. Am J Kidney Dis 10:208-221, 1987.
29. Border WA, Cohen AH: Renal biopsy diagnosis of clinically silent multiple myeloma. Ann Intern Med 93:43-46, 1980.
30. Sanders PW, Booker BB: Pathobiology of cast nephropathy from human Bence-Jones proteins. J Clin Invest 89:630-639, 1992.
31. Iggo N, Palmer AB, Severn A, Tafford JA, Mufti GJ, Taube D, Parsons V: Chronic dialysis in patients with myeloma and renal failure: a worthwhile treatment. QJ Med 73:903-910, 1989.
32. Korzets A, Tam F, Russell G, Feehally J, Walls J: The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to myeloma. Am J Kidney Dis 16:216-223, 1990.
33. Hannisdal E, Kildahl-Anderson O, Grottum KA, Lamvik J: Prognostic factors in multiple myeloma in a population based trial. Eur J Haematol 45:198-202, 1990.
34. Coward RA, Mallick NP, Delamore JW: Should patients with renal failure associated with myeloma be dialysed? Br Med J 287:1575-1578, 1983.
35. Bernstein SP, Humes ND: Reversible renal insufficiency in multiple myeloma. Arch Intern Med 142:2083-2086, 1982.
36. Misiani R, Tirabaschi G, Mingardi G, Mecca G: Management of myeloma kidney: An anti-light chain approach. Am J Kidney Dis 10:28-33, 1987.
37. Rose PE, McGonigle R, Michael J, Biughton, BJ: Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J 294:411-412, 1987.
38. Cavo M, Baccarani M, Galieni P, Gobbi M, Tura S: Renal failure in multiple myeloma: A study of the presenting findings, response to treatment and prognosis in 26 patients. Nouv Rev Fr Hematol 28:147-152, 1986.
39. Ganeval D, Jungers P, NoScript J sign1 LH, Droz D: La nephropathie du my - lome. In: Hamburger J, Crosnier J, F∫nck-Brentano JL (eds); Actualites nephrologiques de Hospital Necker, Flammarion, Paris, 1977,pp 309-347.
40. Penn I: Kidney transplantation following treatment of tumors. Transplant Proc 18 (suppl 3): 16-20, 1986.
41. Wahlin A, Lofvenberg E, Holm J: Improved survival in multiple myeloma with renal failure. Acta Med Scand 221:205-209, 1987.